EFX
41
-5
SNA
65
-3
ZION
69
-2
DHR
41
2
MMC
67
2
HAL
62
-2
WHR
65
-7
RSG
76
2
LLY
53
6
BWA
48
-5
PFG
50
-2
URBN
50
-2
KO
47
-2
BF.B
33
-4
EMC
56
-3
F
54
-6
HCP
62
-8
HBI
59
4
BXP
60
5
MAT
41
-4
EFX
41
-5
SNA
65
-3
ZION
69
-2
DHR
41
2
MMC
67
2
HAL
62
-2
WHR
65
-7
RSG
76
2
LLY
53
6
BWA
48
-5
PFG
50
-2
URBN
50
-2
KO
47
-2
BF.B
33
-4
EMC
56
-3
F
54
-6
HCP
62
-8
HBI
59
4
BXP
60
5
MAT
41
-4
Financhill
Back

GlycoMimetics Vs. Revance Therapeutics Industry Stock Comparison

Sell
50

GLYC
GlycoMimetics

Last Price:
0.30
Seasonality Move:
11.03%
Sell
17

RVNC
Revance Therapeutics

Last Price:
4.16
Seasonality Move:
6.97%
Sell
50
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $4.02. The Score for RVNC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.32
    The current trend is moderately bearish and GLYC is experiencing slight buying pressure.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $4.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight selling pressure.

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 48.97 Sell
Chaikin Money Flow: 296581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.26 - 0.44) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 39.81 Sell
Chaikin Money Flow: -197589 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.84 - 5.68) Sell
Bollinger Bands (100): (3.83 - 6.27) Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.35 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.26 Buy
200-day SMA: 0.93 Sell
8-day EMA: 0.34 Sell
20-day EMA: 0.34 Sell
50-day EMA: 0.3 Buy
200-day EMA: 0.73 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.89 Buy
20-day SMA: 4.59 Sell
50-day SMA: 5.07 Sell
200-day SMA: 4.58 Sell
8-day EMA: 3.96 Buy
20-day EMA: 4.38 Sell
50-day EMA: 4.85 Sell
200-day EMA: 5.97 Sell

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):